MAC Lung Infection Study
We're recruiting participants for a clinical study to evaluate the safety and effectiveness of a potential treatment option for patients with nontuberculous mycobacteria (NTM).
Please see below for the key eligibility criteria.
Please note that study-related costs, including those associated with travel to the study clinic, may be reimbursed – you can speak with your site coordinator to learn more about the details.
If you are interested in learning more, click the link below to register your interest.
Eligibility
- 18 years or older
- Newly diagnosed with Nontuberculous Mycobacterial (NTM) lung infection caused by Mycobacterium avium Complex (MAC)
- Willing to participate in the trial for 18 months
Location
- QLD
- SA
- VIC